default author photo

Anil K. Sood

University of Texas at Houston - Department of Gynecologic Oncology

1901 East Road, Unit 1950

Unit 1905

Houston, TX 77030

United States

SCHOLARLY PAPERS

4

DOWNLOADS

302

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Pelvic Fractures and Changes in Bone Mineral Density Following Radiotherapy for Cervical, Endometrial and Vaginal Cancer: A Prospective Study of 239 Women

Number of pages: 33 Posted: 27 Nov 2019
Federal University of Health Sciences of Porto Alegre (UFCSPA), University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Diagnostic Radiology, University of Texas at Houston, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 121 (592,433)

Abstract:

Loading...

radiotherapy; survivorship; pelvic fractures; cervical cancer; endometrial cancer; vaginal cancer; osteoporosis; bone mineral density

2.

PTGER3 Induces Ovary Tumorigenesis and Confers Resistance to Cisplatin Therapy Through Up-Regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 Axis

, EBioMedicine, 40, 290-304. https://doi.org/10.1016/j.ebiom.2018.11.045
Number of pages: 1 Posted: 22 Dec 2018
University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Houston Methodist Research Institute - Department of Nanomedicine, University of Texas at Houston - Department of Experimental Therapeutics, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Houston Methodist Research Institute - Department of Nanomedicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Experimental Therapeutics, Houston Methodist Research Institute - Department of Nanomedicine, AM Biotechnologies LLC, University of Texas at Houston - Department of Gynecologic Oncology and University of Texas at Houston - Department of Experimental Therapeutics
Downloads 103 (674,591)

Abstract:

Loading...

PTGER3, ovarian cancer, RNA interference, chemically modified siRNA, cisplatin resistance, ETS1, ELK1, CFTR

3.

Exosomal Mirna Confers Chemo Resistance Via Targeting Cav1/p-gp/M2-Type Macrophage Axis in Ovarian Cancer

, EBioMedicine, Volume 38, December 2018, Pages 100-112, https://doi.org/10.1016/j.ebiom.2018.11.004
Number of pages: 45 Posted: 20 Sep 2018
University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Rutgers University, New Brunswick, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Hacettepe University, Rutgers University, New Brunswick, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and University of Texas at Houston - Department of Experimental Therapeutics
Downloads 44 (1,133,231)

Abstract:

Loading...

exosome, oncomiR, miR-1246, ovarian cancer, Cav1, chemoresistance

4.

Endothelial p130cas Confers Resistance to Anti-Angiogenesis Therapy

Number of pages: 51 Posted: 13 Aug 2020
University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Gynecologic Oncology, University of Texas at Houston - Department of Experimental Therapeutics, University of Texas at Houston - Department of Molecular and Cellular Oncology and University of Texas at Houston - Department of Gynecologic Oncology
Downloads 34 (1,263,436)

Abstract:

Loading...

Vascular p130cas, nuclear VEGFR2, autophagy, CRISPR-CAS9, mass spectrometry, TNKS1BP1, adaptive resistance, p130casflox/floxTie2Cre mice, anti-angiogenic therapy